Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cipher Pharmaceuticals Inc (CPH.TO)

Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 212,385
  • Shares Outstanding, K 24,107
  • Annual Sales, $ 21,162 K
  • Annual Income, $ 20,383 K
  • 60-Month Beta 0.47
  • Price/Sales 7.46
  • Price/Cash Flow 10.19
  • Price/Book 1.92
Trade CPH.TO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.14
  • Number of Estimates 1
  • High Estimate 0.14
  • Low Estimate 0.14
  • Prior Year 0.14
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.90 +7.72%
on 04/01/24
9.98 -14.73%
on 03/26/24
-0.65 (-7.10%)
since 03/22/24
3-Month
5.54 +53.61%
on 01/25/24
9.98 -14.73%
on 03/26/24
+2.91 (+51.96%)
since 01/24/24
52-Week
3.11 +173.63%
on 05/08/23
9.98 -14.73%
on 03/26/24
+5.14 (+152.52%)
since 04/24/23

Most Recent Stories

More News
Stocks in play: Cipher Pharmaceuticals

Will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take ...

CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference

Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will...

CPHRF : 6.2300 (-4.15%)
CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced its financial and operating results for the year...

CPHRF : 6.2300 (-4.15%)
CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the...

CPHRF : 6.2300 (-4.15%)
CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or "the Company") is proud to announce that its common shares are now trading on the...

CPHRF : 6.2300 (-4.15%)
CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Announces Change of Auditor

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it has changed its auditors from Ernst & Young LLP ("Former...

CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Announces Normal Course Issuer Bid

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has...

CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and nine months...

CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the third quarter of...

CPH.TO : 8.51 (-3.41%)
Cipher Pharmaceuticals Announces Final Results of Substantial Issuer Bid

/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company"), today announced the final results of its substantial issuer bid (the "Offer"),...

CPH.TO : 8.51 (-3.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

See More

Key Turning Points

3rd Resistance Point 8.99
2nd Resistance Point 8.90
1st Resistance Point 8.70
Last Price 8.51
1st Support Level 8.41
2nd Support Level 8.32
3rd Support Level 8.12

See More

52-Week High 9.98
Last Price 8.51
Fibonacci 61.8% 7.36
Fibonacci 50% 6.54
Fibonacci 38.2% 5.73
52-Week Low 3.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar